Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX2 | P34913 | 9/20 | 0.34 |
| ▸ | HSPD1 | P10809 | 1/20 | 0.32 |
| ▸ | BLM | P54132 | 1/20 | 0.32 |
| ▸ | HSPE1 | P61604 | 1/20 | 0.32 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.32 |
| ▸ | S1PR4 | O95977 | 1/20 | 0.31 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.31 |
| ▸ | S1PR3 | Q99500 | 1/20 | 0.31 |
| ▸ | S1PR5 | Q9H228 | 1/20 | 0.31 |
| ▸ | GBA2 | Q9HCG7 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9736531 | 1.00 | EPHX2 (0.34) | EPHX2HSPD1BLMHSPE1HCAR2 | |
| SCHEMBL7476617 | 1.00 | EPHX2 (0.34) | EPHX2HSPD1BLMHSPE1HCAR2 | |
| SCHEMBL6723835 | 0.90 | CYP2D6 (0.30) | — | |
| SCHEMBL6047499 | 0.89 | EPHX2 (0.33) | EPHX2HCAR2S1PR1S1PR3S1PR5 | |
| SCHEMBL28538099 | 0.89 | EPHX2 (0.33) | EPHX2HCAR2S1PR1S1PR3S1PR5 | |
| SCHEMBL14795049 | 0.89 | EPHX2 (0.33) | EPHX2HCAR2S1PR1S1PR3S1PR5 | |
| SCHEMBL3951980 | 0.87 | PPARG (0.36) | EPHX2 | |
| SCHEMBL7698297 | 0.86 | NAAA (0.32) | — | |
| SCHEMBL39175 | 0.86 | PPARG (0.39) | EPHX2 | |
| SCHEMBL995960 | 0.86 | PPARG (0.39) | EPHX2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 185 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260071126-A1 | Polymerizable Liquid Crystal Material and Polymerized Liquid Crystal Film | MERCK PATENT GMBH (DE) | 2026-03-12 | — | — | US | disclosed |
| US-12570900-B2 | Polymerisable compound, polymerisable LC material and polymer film | MERCK PATENT GMBH (DE) | 2026-03-10 | — | — | US | disclosed |
| US-12565617-B2 | Polymerisable oligomeric liquid crystal, polymerisable medium and polymerised liquid crystal film | MERCK PATENT GMBH (DE) | 2026-03-03 | — | — | US | disclosed |
| US-20260055243-A1 | GREEN PREPARATION METHOD FOR GRANULAR PLASTIC ADDITIVES | BASF SE (DE) | 2026-02-26 | — | — | US | disclosed |
| US-20250361445-A1 | POLYMERISABLE LIQUID CRYSTAL MEDIUM AND POLYMERISED LIQUID CRYSTAL FILM | MERCK PATENT GMBH (DE) | 2025-11-27 | — | — | US | disclosed |
| EP-4573149-A1 | GREEN PREPARATION METHOD FOR GRANULAR PLASTIC ADDITIVES | BASF SE (DE) | 2025-06-25 | — | — | EP | disclosed |
| EP-4217442-B1 | POLYMERIZABLE LIQUID CRYSTAL MATERIAL AND POLYMERIZED LIQUID CRYSTAL FILM | MERCK PATENT GMBH (DE) | 2025-06-18 | — | — | EP | disclosed |
| US-12187946-B2 | Polymerisable liquid crystal material and polymerised liquid crystal film | MERCK PATENT GMBH (DE) | 2025-01-07 | — | — | US | disclosed |
| US-12162834-B2 | Reactive mesogens | MERCK PATENT GMBH (DE) | 2024-12-10 | — | — | US | disclosed |
| US-20240400900-A1 | POLYMERISABLE COMPOUND, POLYMERISABLE LC MATERIAL AND POLYMER FILM | MERCK PATENT GMBH (DE) | 2024-12-05 | — | — | US | disclosed |
| EP-0892827-B1 | STABILIZER COMPOSITION | CLARIANT FINANCE BVI LTD (VG) | 2004-07-07 | — | — | EP | disclosed |
| EP-1155098-B1 | LIQUID CRYSTALLINE SUBSTANCE MIXTURES | BASF AG (DE) | 2004-05-26 | — | — | EP | disclosed |
| US-6733689-B1 | ACRYLIC ESTER AND VINYL ETHER LIQUID CRYSTAL POLYMERS | BASF DRUCKSYSTEME GMBH (DE) | 2004-05-11 | — | — | US | disclosed |
| US-6365652-B2 | AMIDO OR CARBAMATE SUBSTITUTED TRISARYL-1,3,5-TRIAZINES USED AS ACTINIC RADIATION STABILIZER BY INCORPORATING THE ABOVE COMPOUND INTO THE ORGANIC POLYMER BY CHEMICAL BONDING | CIBA SPECIALTY CHEMICALS CORPORATION | 2002-04-02 | — | — | US | disclosed |
| US-20010037022-A1 | Trisaryl-1,3,5-triazine ultraviolet light absorbers | GUPTA RAM BABOO (US) | 2001-11-01 | — | — | US | disclosed |
| US-6265576-B1 | STABILIZERS | CIBA SPECIALTY CHEMICALS CORPORATION | 2001-07-24 | — | — | US | disclosed |
| EP-0942037-A1 | Polymer dispersions or solutions containing stabilisers and polymer preparations obtainable therefrom | BASF AKTIENGESELLSCHAFT (DE) | 1999-09-15 | — | — | EP | disclosed |
| EP-0309402-B1 | N-substituted hindered amine stabilizers | CIBA GEIGY AG (CH) | 1995-01-11 | — | — | EP | disclosed |
| US-5204473-A | O-substituted N-hydroxy hindered amine stabilizers | CIBA-GEIGY CORPORATION (US) | 1993-04-20 | — | — | US | disclosed |
| EP-0309402-A1 | N-substituted hindered amine stabilizers | CIBA-GEIGY AG (CH) | 1989-03-29 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260055243-A1 | GREEN PREPARATION METHOD FOR GRANULAR PLASTIC ADDITIVES | GRN, FUS, MAPT | EPHX2 4802/4885HSPD1 265/4885BLM 1267/4885 |
| US-12570900-B2 | Polymerisable compound, polymerisable LC material and polymer film | L3MBTL3, L3MBTL1, L3MBTL4 | EPHX2 1971/4885HSPD1 4885/4885BLM 778/4885 |
| US-20260071126-A1 | Polymerizable Liquid Crystal Material and Polymerized Liquid Crystal Film | MLX, SCO2, VCL | EPHX2 2917/4885HSPD1 4838/4885BLM 25/4885 |
| US-20010037022-A1 | Trisaryl-1,3,5-triazine ultraviolet light absorbers | CRYZ, ERCC5, TELO2 | EPHX2 724/4885HSPD1 4485/4885BLM 1553/4885 |
| US-12565617-B2 | Polymerisable oligomeric liquid crystal, polymerisable medium and polymerised liquid crystal film | NOD1, OSTC, MLX | EPHX2 2214/4885HSPD1 4258/4885BLM 254/4885 |
| US-12162834-B2 | Reactive mesogens | BLM, MAS1, MCHR1 | EPHX2 2697/4885HSPD1 3058/4885BLM 1/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.